Quick Answer
Sonoma Pharmaceuticals, Inc. reported Total Assets of $13.69 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed a decrease of -7.1% in Total Assets from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $7.76 million | Q4 2011: $8.98 million | Q3 2012: $13.39 million | Q4 2012: $11.83 million | Q2 2013: $10.58 million | Q3 2013: $8.88 million | Q4 2013: $9.84 million | Q2 2014: $19.88 million | Q3 2014: $18.39 million | Q4 2014: $11.83 million | Q2 2015: $14.21 million | Q3 2015: $13.58 million | Q4 2015: $12.10 million | Q2 2016: $11.32 million | Q3 2016: $9.24 million | Q4 2016: $27.51 million | Q2 2017: $22.42 million | Q3 2017: $20.15 million | Q4 2017: $18.36 million | Q2 2018: $16.63 million | Q3 2018: $14.35 million | Q4 2018: $17.05 million | Q2 2019: $16.92 million | Q3 2019: $16.15 million | Q4 2019: $16.50 million | Q2 2020: $18.65 million | Q3 2020: $18.15 million | Q4 2020: $18.23 million | Q2 2021: $14.12 million | Q3 2021: $19.83 million | Q4 2021: $19.35 million | Q2 2022: $17.16 million | Q3 2022: $14.96 million | Q4 2022: $13.93 million | Q2 2023: $15.89 million | Q3 2023: $13.64 million | Q4 2023: $14.62 million | Q2 2024: $13.67 million | Q3 2024: $13.69 million | Q4 2024: $13.67 million | Q1 2025: $13.69 million | Q2 2025: $14.59 million | Q3 2025: $13.86 million | Q4 2025: $13.62 million.
- Over the full 15 years of available data (2011 to 2025), Sonoma Pharmaceuticals, Inc.'s Total Assets has grown by 58.0%.
- Historical annual values: Fiscal year 2025: $13.69 million | Fiscal year 2024: $14.74 million | Fiscal year 2023: $16.23 million | Fiscal year 2022: $18.85 million | Fiscal year 2021: $14.99 million | Fiscal year 2020: $14.56 million | Fiscal year 2019: $14.45 million | Fiscal year 2018: $19.21 million | Fiscal year 2017: $25.46 million | Fiscal year 2016: $13.80 million | Fiscal year 2015: $15.05 million | Fiscal year 2014: $20.79 million | Fiscal year 2013: $12.57 million | Fiscal year 2012: $7.84 million | Fiscal year 2011: $8.66 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: